Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, suppresses the expression of telomerase via down regulation of its target gene, 13/April/2014, 8.45 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation